//
Laygend Foundation is a private corporation based in RCHO SANTA FE, CA. The foundation received its IRS ruling in 2022. The principal officer is % Brian P Tsu. It holds total assets of $113.2M. Annual income is reported at $17.8M. In 2022, Laygend Foundation established an endowment fund with UC San Diego Bioengineering Department in supporting and empowering UC San Diego bioengineering department to build on its well-recognized strengths in teaching, research and biotechnology workforce development in the future years and in honoring Shu Chien, a UC San Diego emeritus professor of bioengineering and medicine who is a renowned bioengineering researcher, educator and mentor. The first grant of $2.5 million was gifted in 2022. According to available records, Laygend Foundation has made 4 grants totaling $12.5M, with a median grant of $2.5M. Annual giving has grown from $5M in 2022 to $7.5M in 2023. Individual grants have ranged from $2.5M to $5M, with an average award of $3.1M. The foundation has supported 2 unique organizations. Grants have been distributed to organizations in California and Massachusetts. Contributions to this foundation are tax-deductible.
In 2022, Laygend Foundation established an endowment fund with UC San Diego Bioengineering Department in supporting and empowering UC San Diego bioengineering department to build on its well-recognized strengths in teaching, research and biotechnology workforce development in the future years and in honoring Shu Chien, a UC San Diego emeritus professor of bioengineering and medicine who is a renowned bioengineering researcher, educator and mentor. The first grant of $2.5 million was gifted in 2022.
In 2022, Laygend Foundation established an endowment fund with UC San Diego Bioengineering Department in supporting and empowering UC San Diego bioengineering department to build on its well-recognized strengths in teaching, research and biotechnology workforce development in the future years and in honoring Shu Chien, a UC San Diego emeritus professor of bioengineering and medicine who is a renowned bioengineering researcher, educator and mentor. The first grant of $2.5 million was gifted in 2022. Based on available records, the foundation has funded 4 grants. Its grantmaking reaches organizations primarily in CA, MA.
Laygend Foundation has distributed a total of $12.5M across 4 grants. The median grant size is $2.5M, with an average of $3.1M. Individual grants have ranged from $2.5M to $5M.
Laygend Foundation typically selects its grantees rather than accepting unsolicited proposals.
Laygend Foundation is headquartered in RCHO SANTA FE, CA. While based in CA, the foundation distributes grants to organizations across 2 states.
| Name | Title | Compensation | Benefits | Total |
|---|---|---|---|---|
| Mintsen Chen | Treasurer | $0 | $0 | $0 |
| Jeng-Guang Lay | President & CEO | $0 | $0 | $0 |
| Nan Jiang | Secretary | $0 | $0 | $0 |
Total Giving
$7.5M
Total Assets
$128.6M
Fair Market Value
$0
Net Worth
$128.6M
Grants Paid
$7.5M
Contributions
$5K
Net Investment Income
$669K
Distribution Amount
$6.8M
Total: $0
Total Grants
4
Total Giving
$12.5M
Average Grant
$3.1M
Median Grant
$2.5M
Unique Recipients
2
Most Common Grant
$2.5M
of 2023 grantees were first-time recipients
| Recipient | Location | Amount | Year |
|---|---|---|---|
| Havard Brigham And Woman HospitalLaygend Foundation established Gene Lay Institute of Immunology and Inflammation in May 2023 and pledged an endowment fund in supporting and empowering multi-institution team and collective efforts of Brigham & Woman Hospital, Massachusetts General Hospital and Harvard Medical School for research activities in the areas of immunology and Inflammation and translate research discovery into therapies and bring solutions to patients and families. The primary areas of research will include basic unde | Boston, MA | $5M | 2023 |
| Regents Of University Of CaliforniaPostsecondary Education:The endowment will build on the UCSD's Department of Bioengineering excellence by providing transformative annual recurring support for research and education. Collectively, this funding will be critical for the department's efforts to bridge gaps between bioengineering research and clinical impacts that directly improve human health. | La Jolla, CA | $2.5M | 2023 |
CHICAGO, IL
SEATTLE, WA
LLOYD HARBOR, NY
FOSTER CITY, CA
SAN DIEGO, CA
© 2026 Granted AI